Navigation Links
USP applauds nomination of Dr. Margaret Hamburg as FDA Commissioner
Date:3/16/2009

Rockville, Md., March 16, 2009 Noting the growing importance of drug and food quality on the nation's agenda, Roger L. Williams, M.D., chief executive officer of the U.S. Pharmacopeial (USP) Convention, today issued the following statement regarding the nomination of Dr. Margaret Hamburg as commissioner of food and drugs of the U.S. Food and Drug Administration (FDA):

"USP congratulates Dr. Hamburg on her nomination as FDA commissioner. She has the scientific and managerial credentials and experience that are needed at the helm of FDA at this critical point. That background will help her to guide the FDA, which faces complex challenges in protecting the safety of the drug and food supplies in the modern, global manufacturing environment."

For more than a century, FDA and USP have worked closely in a unique partnership to assure that the public has access to high-quality medicines. Under the Federal Food, Drug, and Cosmetic Act, prescription and over-the-counter medicines sold in the United States must comply with the public standards for identity, quality, purity and strength set forth in USP's book of standards, the United States Pharmacopeia. These standards, developed by USP with volunteers from the scientific community in an open public process, are enforced by FDA. USP also sets standards for food ingredients and dietary supplements.

According to Dr. Williams, "Up-to-date standards are critical in protecting the public's health and safetyparticularly important in the context of import safety and concerns about adulteration and contamination. The benefits of this FDA-USP partnership to address emerging public health threats related to drug quality were evidenced by the recent improvements to standards for the blood thinner heparin and the binding agent and sweetener glycerintwo widely used drug products involved in recent fatal episodes of adulteration."

As detailed in a recent letter to Acting FDA Commissioner Frank M. Torti, M.D., M.P.H. (available at www.usp.org), USP is committed to supporting FDA with scientific expertise and to working together to protect consumers through standards.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. AstraZeneca Applauds Appointment of New FDA Commissioner
2. APS applauds Senate passage of FY09 omnibus bill
3. Religious Coalition for Reproductive Choice President Applauds Obama Stem Cell Policy
4. CAMR Applauds President Obamas Commitment to Embryonic Stem Cell Research
5. ASPS Applauds Introduction of Legislation to Increase Access to Reconstructive Surgery for Children
6. CPTA Applauds Legislation to Ease Patient Access to Physical Therapy Services
7. National Medical Association Applauds President Obama for Convening the White House Forum on Health Reform
8. Council for Quality Respiratory Care Applauds President Obamas Appointments of Governor Sebelius, DeParle to Lead Health Care Efforts
9. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Gov. Sebelius for Secretary of Health and Human Services
10. UPDATED: DGA Leadership Applauds Gov. Sebelius Cabinet Appointment
11. DGA Chair Gov. Schweitzer Applauds Gov. Sebelius Cabinet Appointment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: